BRAF and neoplasm: The aim of this manuscript is to use established early response assessments such as ETS and DpR as well as time-to-DpR and survival beyond DpR as novel parameters related to these endpoints to elucidate to which extent the negative prognostic impact of BRAF mutation and right-sided tumor localization can be characterized by these parameters.